Inhibition of Glucose Uptake Blocks Proliferation but Not Cytotoxic Activity of NK Cells

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Regulation

Background:

• Tumor cells exhibit high energy demands, making glucose uptake inhibition a potential anti-cancer strategy.
• Immune cells, including Natural Killer (NK) cells crucial for cancer immunosurveillance, also rely on glucose for optimal function.
• Understanding the metabolic interplay between cancer and immune cells is vital for developing effective immunotherapies.

Purpose of the Study:

• To investigate the impact of Glutor, a glucose transporter inhibitor, on human NK cell function.
• To determine how metabolic inhibition affects NK cell proliferation, effector functions, and cytokine production.
• To assess the robustness of NK cell cytotoxic activity against metabolic disturbances.

Main Methods:

• Treatment of human NK cells with Glutor, a glycolysis inhibitor.
• Assessment of NK cell proliferation, cytotoxicity, and serial killing activity.
• Analysis of pro-inflammatory regulatory functions and IFN-γ production following Glutor exposure.

Main Results:

• Glutor effectively inhibits glycolysis in NK cells.
• Acute Glutor treatment does not impair NK cell effector functions.
• Prolonged Glutor exposure reduces NK cell proliferation and IFN-γ production but preserves cytotoxicity and serial killing.
• Prolonged Glutor treatment enhances NK cell pro-inflammatory regulatory function.

Conclusions:

• NK cell effector functions, particularly cytotoxicity, demonstrate remarkable resilience to metabolic perturbations induced by glucose uptake inhibition.
• Targeting glucose metabolism in cancer therapy may necessitate careful consideration of its impact on anti-tumor immune responses mediated by NK cells.
• Metabolic interventions could modulate NK cell function, potentially enhancing regulatory roles while maintaining cytotoxic capacity.